Download Files:
Products Details
Product Description
– Anti-IAV agent 1 (Compound (R)-1a) is an orally active anti-influenza A virus (IAV) agent with IC50s of 0.03 and 0.06 μM against IAV H1N1 and Oseltamivir-resistant IAV H1N1 strains, respectively[1].
Web ID
– HY-151967
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C28H28FN9O3
References
– [1]Wu W, et al. Optimization and SAR research at the benzoxazole and tetrazole rings of JNJ4796 as new anti-influenza A virus agents, part 2. Eur J Med Chem. 2023 Jan 5;245(Pt 1):114906.
Molecular Weight
– 557.58
SMILES
– CC(NC1=CC2N=C(OC2C=C1)C3=CC(C(N4CCN(CC4)[C@@H](C5=NN(C)N=N5)C6=CC=C(C=C6)F)=O)=NC=C3)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
